The National Immunobiological Company Developed a Multivalent Vaccine For Prophylaxis of Measles, Rubella and Parotitis «Vactrivir»

Editorial Article

Epidemiology and Vaccinal Prevention
Èpidemiologiâ i vakcinoprofilaktika

ISSN 2073-3046 (Print)
ISSN 2619-0494 (Online)

User

eng | рус

Epidemiology and Vaccinal Prevention

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Article E. The National Immunobiological Company Developed a Multivalent Vaccine For Prophylaxis of Measles, Rubella and Parotitis «Vactrivir». Epidemiology and Vaccinal Prevention. 2017;16(1):75-75. (In Russ.)

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2073-3046 (Print)
ISSN 2619-0494 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Epidemiology and Vaccinal Prevention

For citations:

Cookies policy